Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase I/II study investigating lead ...

Updated results from the Phase III ELATIVE trial reveal Iqirvo (elafibranor) significantly reduced fatigue in patients with ...

Superbooth 25: Korg has been teasing an ‘acoustic synthesis’ product for a couple of years now. We first got wind of it at ...

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

Chirality—the property of an object that is distinct from its mirror image—has long captivated scientists across biology, ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today ...

In a multicenter, retrospective, observational study, researchers examined real-world outcomes of patients with drug-resistant epilepsy treated with cenobamate as adjunctive treatment to other ...

IN BRIEFUS Patent Office granted Active Biotech's patent application for laquinimod in eye disorders (January 28)Active Biotech announced that the first patient was enrolled in the European ...

Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Incyte Corp. v. Sun ...

Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b ...

A Princeton team uncovered a surprising chiral quantum state in a supposedly non-chiral material, shedding light on elusive symmetry-breaking effects and opening doors to new quantum technologies.